X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (6) 6
humans (6) 6
index medicus (6) 6
cardiopulmonary bypass (5) 5
female (5) 5
male (5) 5
coronary artery bypass (4) 4
health aspects (4) 4
quality of life (4) 4
follow-up studies (3) 3
morbidity (3) 3
patient outcomes (3) 3
research (3) 3
risk factors (3) 3
abridged index medicus (2) 2
aged patients (2) 2
aged, 80 and over (2) 2
beating heart (2) 2
cardiac & cardiovascular systems (2) 2
care and treatment (2) 2
coronary artery bypass, off-pump - mortality (2) 2
cost-benefit analysis (2) 2
denmark (2) 2
metaanalysis (2) 2
middle aged (2) 2
mortality (2) 2
myocardial infarction - mortality (2) 2
postoperative complications - mortality (2) 2
prospective studies (2) 2
surveys and questionnaires (2) 2
usage (2) 2
adolescent (1) 1
adult (1) 1
age distribution (1) 1
age factors (1) 1
algorithms (1) 1
anticholesteremic agents - administration & dosage (1) 1
anticholesteremic agents - adverse effects (1) 1
arthroscopy (1) 1
artikkel (1) 1
atherosclerosis (1) 1
baltic sea (1) 1
bleeding (1) 1
blood cholesterol (1) 1
blood pressure (1) 1
canada - epidemiology (1) 1
cardioplegic arrest (1) 1
cardiopulmonary bypass - mortality (1) 1
cardiovascular disease (1) 1
cardiovascular diseases (1) 1
cardiovascular diseases - chemically induced (1) 1
cardiovascular diseases - epidemiology (1) 1
cardiovascular diseases - etiology (1) 1
cardiovascular risk (1) 1
chi-square distribution (1) 1
cholesterol, hdl - blood (1) 1
cholesterol, hdl - drug effects (1) 1
cholesterol, ldl - blood (1) 1
cholesterol, ldl - drug effects (1) 1
clinical-practice (1) 1
coastal eutrophication (1) 1
coastal waters (1) 1
consent (1) 1
controlled-trials (1) 1
coronary artery bypass - adverse effects (1) 1
coronary artery bypass - economics (1) 1
coronary artery bypass - mortality (1) 1
coronary artery bypass surgery cost-effectiveness (1) 1
coronary artery bypass, off-pump (1) 1
coronary artery bypass, off-pump - adverse effects (1) 1
coronary artery bypass, off-pump - economics (1) 1
coronary artery disease (1) 1
coronary artery disease - economics (1) 1
coronary artery disease - surgery (1) 1
coronary-artery-bypass (1) 1
coronary-heart-disease (1) 1
critical care (1) 1
critical illness - mortality (1) 1
critical illness - therapy (1) 1
cross-sectional studies (1) 1
damage (1) 1
danish on-pump (1) 1
denmark - epidemiology (1) 1
density-lipoprotein cholesterol (1) 1
diabetes (1) 1
diabetes mellitus (1) 1
diabetes mellitus, type 2 - blood (1) 1
diabetes mellitus, type 2 - complications (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diabetes mellitus, type 2 - epidemiology (1) 1
diabetic angiopathies - blood (1) 1
diabetic angiopathies - chemically induced (1) 1
diabetic angiopathies - epidemiology (1) 1
diabetic angiopathies - etiology (1) 1
diabetics (1) 1
disease-activity (1) 1
double-blind method (1) 1
dyslipidaemia (1) 1
dyslipidemias - chemically induced (1) 1
dyslipidemias - epidemiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Scandinavian Cardiovascular Journal, ISSN 1401-7431, 06/2013, Volume 47, Issue 3, pp. 185 - 192
Journal Article
by Leiter, L. A and Lundman, P and da Silva, P. M and xel, H and Jünger, C and Gitt, A. K and Absenger, Guun and Albrich, Ernst and Allinger, Berndt and Allinger, Stephan and Anacher, Gerald and Angermayr, Gertraud and Angermeier, Hermann and Anzengruber, Aneas and Archimanitis, Gabriele and Arnsteiner, Patricia and Auberger, Wolfgang and Azhary, Mawaheb and Barfuss, Michael and Bauer, Christian and Bauer, Birgit Elisabeth and Beclin, Thomas and Binder, Thomas and Binder, Gabriele and Böhler, Dietmar and Brändle, Johann and Breslmair, Jörg and Brettlecker, Marlis and Bürger, Michael and Calvi, Inge and Dorfinger, Werner and Doringer-Schnepf, Elisabeth and Eer, Anton and Eckmayr, Christine and Eder, Franz and Egermann, Margit and Erath, Michael and Etzinger, Michael and Etzinger, Claudia and Fiedler, Lothar and Filip, Wolfgang and Filip, Michaela and Föchterle, Johann and Fodor, Anita and Frieden, Thomas and Gareiss, Mertens and Gföllner, Peter and Ghamarian, Thomas and Goritschan, Michael and Haar, Klaus and Habeler, Gerhard and Hadjiivanov, Valery and Haiböck, Christian and Hammer, Regina and Hartmann, Siegfried and Haschkovitz, Herbert and Hauer, Walter and Hauer, Josef and Haunschmidt, Christian and Heimayr, Christine and Hengl, Wolfgang and Hengl, Gunter and Hermann, Rudolf and Herrmann, Rainer and Hillebrand, Roswitha and Hintersteininger, Otto and Hirsch, Michael and Hitzinger, Martin and Hochegger, Tanja and Hockl, Wolfgang and Hoi, Michael and Hörmann, Jan and Hudler, Brigitte and Imb, Gerhard and Joichl, Anea and Jungbauer, Karl and Kapl, Gerlinde and Kerschbaum, Margit and Kienesberger, Franz and Killinger, Gerhard and Kitzler, Gerhard and Klein, Franz and Kleinbichler, Dietmar and Kohr, Anton and Kopetzky, Michael and Korthals, Christian and Kortschak, Werner and Koschutnik, Martin and Kraus, Werner A and Kurzemann, Susanne and Lavicka, Claus and Lehner, Guido and Lenz, Jürgen and Lepuschütz, Sabine and Lichtenwallner, Michael and Lober, Reinhard and Loidl, Christine and Lopatka, Eduard and Ludwig, Rudolf and Maca, Thomas and ... and DYSIS Investigators and DYSIS investigators
Diabetic medicine, ISSN 0742-3071, 2011, Volume 28, Issue 11, pp. 1343 - 1351
To assess the prevalence of persistent lipid abnormalities in statin-treated patients with diabetes with and without the metabolic syndrome. This was a... 
metabolic syndrome | cardiovascular disease | diabetes mellitus | dyslipidaemia | statins | Cardiovascular disease | Dyslipidaemia | Metabolic syndrome | Diabetes mellitus | Statins | METAANALYSIS | GUIDELINES | PREVENTION | DENSITY-LIPOPROTEIN CHOLESTEROL | THERAPY | REDUCTION | ENDOCRINOLOGY & METABOLISM | CORONARY-HEART-DISEASE | CLINICAL-PRACTICE | CARDIOVASCULAR RISK | LOW HDL-CHOLESTEROL | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Humans | Diabetic Angiopathies - etiology | Male | Metabolic Syndrome - drug therapy | Diabetes Mellitus, Type 2 - epidemiology | Metabolic Syndrome - blood | Canada - epidemiology | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Dyslipidemias - etiology | Diabetes Mellitus, Type 2 - complications | Metabolic Syndrome - epidemiology | Cardiovascular Diseases - etiology | Diabetic Angiopathies - chemically induced | Cross-Sectional Studies | Cholesterol, HDL - drug effects | Europe - epidemiology | Cholesterol, LDL - drug effects | Diabetic Angiopathies - blood | Anticholesteremic Agents - adverse effects | Metabolic Syndrome - complications | Diabetes Mellitus, Type 2 - blood | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Anticholesteremic Agents - administration & dosage | Dyslipidemias - chemically induced | Cholesterol, HDL - blood | Diabetic Angiopathies - epidemiology | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Diabetics | Blood cholesterol | Simvastatin | Low density lipoproteins | Triglycerides | Diabetes | Risk factors | Trans fatty acids | Index Medicus
Journal Article
by Melander, A and Olsson, J and Lindberg, G and Salzman, A and Howard, T and Stang, P and Lydick, E and Emslie-Smith, A and Boyle, D I. R and Evans, J M. M and Macdonald, T M and Bain, J and Sullivan, F and Juhl, C and Pørksen, N and Sturis, J and Hollingdal, M and Pincus, S and Veldhuis, J and Dejgaard, A and Schmitz, O and Kristensen, J S and Frandsen, K B and Bayer, Th and Müller, P and Dunning, B E and Paladini, S and Gutierrez, C and Deacon, R and Valentin, M and Grunberger, G and Weston, W M and Patwardhan, R and Rappaport, E B and Sargeant, L A and Wareham, N J and Khaw, K T and Zethelius, Björn and Lithell, Hans and Hales, C Nicholas and Berne, Christian and Lakka, H.-M and Oksanen, L and Tuomainen, T.-P and Kontula, K and Salonen, J T and Dekker, J M and de Boks, P and de Vegt, F and Stehouwer, C D. A and Nijpels, G and Bouter, L M and Heine, R J and Bruno, G and Cavallo-Perin, P and Bargero, G and D’Errico, N and Borra, M and Macchia, G and Pagano, G and Newton, R W and Ruta, D A and New, J P and Wallace, C and Roxburgh, M A and Young, R J and Vaughan, N J. A and Elliott, P and Brennan, G and Devers, M and MacAlpine, R and Steinke, D and Lawson, D H and Decallonne, B and Casteels, K and Gysemans, C and Bouillon, R and Mathieu, C and Linn, Thomas and Strate, Christine and Schneider, Kerstin and Funda, D P and Jirsa Jr, M and Kozáková, H and Kaas, A and Kofronová, O and Tlaskalová-Hogenová, H and Buschard, K and Wanka, H and Hartmann, A and Kuttler, B and Rasmussen, S B and Sørensen, T S and Markholst, H and Petersen, J S and Karounos, D and Dyrberg, T and Mabley, J G and Haskó, G and Szabó, C and ... and IMDIAB Study Group and Osaka IDDM Study Group and European Group for the Study of Insulin Resistance (EGIR) and Screen-Pol Study Group and Northern Diabetic Pregnancy Survey and Brazilian Gestational Diabetes Study Group and UK Prospective Diabetes Study Group and Hungarian HbA1c Screening Study Group and Croatian Study Group for Diabetic Amyotrophy and EURODIAB IDDM Study Group and Neuropathy Study Group of the Italian Society of the Study of Diabetes and Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and HOE 901/3003 study group and German Working Group on Quality Control and Turkish Diabetes Epidemiology Group and Mauritian NCD group and D.I.O.R. study group and Lithuanian Collaborative Group for the Epidemiology of Diabetes and DARTS/MEMO Collaboration and Cerivastatin/Bezafibrate Latin America Study Group and Pramlintide Type 1 Study Group and Non-Invasive Task Force and Childhood Diabetes in Finland Study Group and German Pediat. Working Group and EURODIAB Complications Study Group and Hvidøre Study group on Childhood Diabetes and EURODIAB Prospective Complications Study (PCS) Group and WHO/IDF Patient Empowerment Workshop and AD Morris for the DARTS/MEMO Collaboration and Pramlintide Type 2 Study Group and Finnish Diabetes Prevention Study Group and Service of internal medecine - diabetologia - vascular diseases and UKPDS Group and IGT Research Group and DAIS Project Group and KANWU study group and Cerivastatin Combination Therapy Study Group and GENEDIAB Study Group and TARDIS Steering Committee and UK centres and Rosiglitazone Study Group and GEDEC study group and HIDM investigators and US Study Group of Insulin Glargine in Type 2 DM and European Insulin Aspart Study Group and The TARDIS Steering Committee and UK centres and The Turkish Diabetes Epidemiology Group and The EURODIAB Prospective Complications Study (PCS) Group and The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and The Finnish Diabetes Prevention Study Group
Diabetologia, ISSN 0012-186X, 8/1999, Volume 42, Issue S1, pp. A1 - A330
Journal Article